Lysyl oxidase-like 2 (LOXL2) a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas
Source: NCBI BioProject (ID PRJNA141413)

0 0

Project name: Homo sapiens
Description: Basal-like breast carcinoma is characterized by the expression of basal/myoepithelial markers, undifferentiated phenotype, highly aggressive behaviour and a frequent triple negative status (ESR-, PR-, Her2neu-). We have previously shown that epithelial-mesenchymal transition (EMT) occurs in basal-like breast tumours and identified Lysyl- Oxidase-Like 2 (LOXL2) as an EMT player and a poor prognosis marker in squamous cell carcinomas. We now show that LOXL2 mRNA is overexpressed in basal-like human breast carcinomas.Identification of new molecular markers in basal breast carcinomasOverall design: 58 (IDC) infiltrative breast ductal carcinoma samples (Grade 3)
Data type: Transcriptome or Gene expression
Sample scope: Multiisolate
Relevance: Medical
Organization: 1.13, Cancer Molecular and celular biology unit, IIB
Literatures
  1. PMID: 21732535
Release date: 2011-10-21
Last updated: 2011-05-27